查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386358

破伤风类毒素疫苗市场报告：2030 年趋势、预测与竞争分析

Tetanus Toxoid Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

破伤风类毒素疫苗趋势与预测

预计到 2030 年，全球破伤风类毒素疫苗市场预计将达到 18.1 亿美元，2024 年至 2030 年年复合成长率为 5.6%。市场的主要驱动因素是破伤风疫苗接种需求的增加、政府加强破伤风疫苗接种推广配合措施以及扩大新型破伤风类毒素疫苗的开发。破伤风类毒素疫苗在医院/诊所和政府市场的全球市场未来性广阔。

破伤风类毒素疫苗市场洞察

Lucintel 预测，由于政府配合措施根除白喉、破伤风和百日咳，预计白喉、破伤风和百日咳在预测期内将出现最高增长。

由于其完善的医疗保健系统，预计北美在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球破伤风类毒素疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球破伤风类毒素疫苗市场趋势（2018-2023）与预测（2024-2030）
  • 全球破伤风类毒素疫苗市场（按类型）
    • 单价破伤风类毒素
    • 破伤风白喉
    • 白喉、破伤风、百日咳
    • 其他的
  • 全球破伤风类毒素疫苗市场（依型态）
    • 四价
    • 五价
    • 六价
  • 全球破伤风类毒素疫苗市场（依最终用途）
    • 医院和诊所
    • 政府机关
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球破伤风类毒素疫苗市场区域分布
  • 北美破伤风类毒素疫苗市场
  • 欧洲破伤风类毒素疫苗市场
  • 亚太地区破伤风类毒素疫苗市场
  • 其他区域破伤风类毒素疫苗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球破伤风类毒素疫苗市场成长机会（按类型）
    • 全球破伤风类毒素疫苗市场成长机会（按型态）
    • 全球破伤风类毒素疫苗市场成长机会（依最终用途）
    • 全球破伤风类毒素疫苗市场成长机会（按地区）
  • 全球破伤风类毒素疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球破伤风类毒素疫苗市场产能
    • 全球破伤风类毒素疫苗市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Merck
  • GlaxoSmithKline
  • Sanofi
  • Pfizer
  • Bharat Biotech
简介目录

Tetanus Toxoid Vaccine Trends and Forecast

The future of the global tetanus toxoid vaccine market looks promising with opportunities in the hospital & clinic and government organisation markets. The global tetanus toxoid vaccine market is expected to reach an estimated $1.81 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are increasing demand for tetanus vaccination, increasing government initiatives to promote tetanus vaccination, and expanding development of new tetanus toxoid vaccines.

A more than 150-page report is developed to help in your business decisions.

Tetanus Toxoid Vaccine by Segment

The study includes a forecast for the global tetanus toxoid vaccine by type, form, end use, and region.

Tetanus Toxoid Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Monovalent Tetanus Toxoid
  • Tetanus-Diphtheria
  • Diphtheria, Tetanus, and Pertussis
  • Others

Tetanus Toxoid Vaccine Market by Form [Shipment Analysis by Value from 2018 to 2030]:

  • Quadrivalent
  • Pentavalent
  • Hexavalent

Tetanus Toxoid Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Government Organisations
  • Others

Tetanus Toxoid Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Tetanus Toxoid Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies tetanus toxoid vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the tetanus toxoid vaccine companies profiled in this report include-

  • Merck
  • GlaxoSmithKline
  • Sanofi
  • Pfizer
  • Bharat Biotech

Tetanus Toxoid Vaccine Market Insights

Lucintel forecasts that diphtheria, tetanus, & pertussis is expected to witness highest growth over the forecast period due to increasing government initiatives for the eradication of these diseases.

North America is expected to witness highest growth over the forecast period due to presence of well-established healthcare systems in the region.

Features of the Global Tetanus Toxoid Vaccine Market

Market Size Estimates: Tetanus toxoid vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Tetanus toxoid vaccine market size by type, form, end use, and region in terms of value ($B).

Regional Analysis: Tetanus toxoid vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, forms, end uses, and regions for the tetanus toxoid vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the tetanus toxoid vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the tetanus toxoid vaccine market size?

Answer: The global tetanus toxoid vaccine market is expected to reach an estimated $1.81 billion by 2030.

Q.2 What is the growth forecast for tetanus toxoid vaccine market?

Answer: The global tetanus toxoid vaccine market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the tetanus toxoid vaccine market?

Answer: The major drivers for this market are increasing demand for tetanus vaccination, increasing government initiatives to promote tetanus vaccination, and expanding development of new tetanus toxoid vaccines.

Q4. What are the major segments for tetanus toxoid vaccine market?

Answer: The future of the tetanus toxoid vaccine market looks promising with opportunities in the hospital & clinic and government organisation markets.

Q5. Who are the key tetanus toxoid vaccine market companies?

Answer: Some of the key tetanus toxoid vaccine companies are as follows:

  • Merck
  • GlaxoSmithKline
  • Sanofi
  • Pfizer
  • Bharat Biotech

Q6. Which tetanus toxoid vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that diphtheria, tetanus, & pertussis is expected to witness highest growth over the forecast period due to increasing government initiatives for the eradication of these diseases.

Q7. In tetanus toxoid vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to presence of well-established healthcare systems in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the tetanus toxoid vaccine market by type (monovalent tetanus toxoid, tetanus-diphtheria, diphtheria, tetanus, & pertussis, and others), form (quadrivalent, pentavalent, and hexavalent), end use (hospitals & clinics, government organisations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Tetanus Toxoid Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Tetanus Toxoid Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Tetanus Toxoid Vaccine Market by Type
    • 3.3.1: Monovalent Tetanus Toxoid
    • 3.3.2: Tetanus-Diphtheria
    • 3.3.3: Diphtheria, Tetanus, & Pertussis
    • 3.3.4: Others
  • 3.4: Global Tetanus Toxoid Vaccine Market by Form
    • 3.4.1: Quadrivalent
    • 3.4.2: Pentavalent
    • 3.4.3: Hexavalent
  • 3.5: Global Tetanus Toxoid Vaccine Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Government Organisations
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Tetanus Toxoid Vaccine Market by Region
  • 4.2: North American Tetanus Toxoid Vaccine Market
    • 4.2.2: North American Tetanus Toxoid Vaccine Market by End Use: Hospitals & Clinics, Government Organisations, and Others
  • 4.3: European Tetanus Toxoid Vaccine Market
    • 4.3.1: European Tetanus Toxoid Vaccine Market by Type: Monovalent Tetanus Toxoid, Tetanus-Diphtheria, Diphtheria, Tetanus, & Pertussis, and Others
    • 4.3.2: European Tetanus Toxoid Vaccine Market by End Use: Hospitals & Clinics, Government Organisations, and Others
  • 4.4: APAC Tetanus Toxoid Vaccine Market
    • 4.4.1: APAC Tetanus Toxoid Vaccine Market by Type: Monovalent Tetanus Toxoid, Tetanus-Diphtheria, Diphtheria, Tetanus, & Pertussis, and Others
    • 4.4.2: APAC Tetanus Toxoid Vaccine Market by End Use: Hospitals & Clinics, Government Organisations, and Others
  • 4.5: ROW Tetanus Toxoid Vaccine Market
    • 4.5.1: ROW Tetanus Toxoid Vaccine Market by Type: Monovalent Tetanus Toxoid, Tetanus-Diphtheria, Diphtheria, Tetanus, & Pertussis, and Others
    • 4.5.2: ROW Tetanus Toxoid Vaccine Market by End Use: Hospitals & Clinics, Government Organisations, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Tetanus Toxoid Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Tetanus Toxoid Vaccine Market by Form
    • 6.1.3: Growth Opportunities for the Global Tetanus Toxoid Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Tetanus Toxoid Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Tetanus Toxoid Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Tetanus Toxoid Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Tetanus Toxoid Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Merck
  • 7.2: GlaxoSmithKline
  • 7.3: Sanofi
  • 7.4: Pfizer
  • 7.5: Bharat Biotech